Ken Griffin Aziyo Biologics, Inc. Transaction History
Citadel Advisors LLC
- $559 Billion
- Q4 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Aziyo Biologics, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 22,431 shares of AZYO stock, worth $32,524. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,431Holding current value
$32,524% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding AZYO
# of Institutions
33Shares Held
13.1MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD3.07MShares$4.46 Million1.8% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.86MShares$4.15 Million0.21% of portfolio
-
Silverarc Capital Management, LLC1.78MShares$2.58 Million0.62% of portfolio
-
Birchview Capital, LP Burlington, VT1.23MShares$1.78 Million1.52% of portfolio
-
Knollwood Investment Advisory, LLC Hunt Valley, MD935KShares$1.36 Million0.37% of portfolio
About AZIYO BIOLOGICS, INC.
- Ticker AZYO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 9,308,720
- Market Cap $13.5M
- Description
- Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of inf...